Exchange: NASDAQ·Updated 07:42 AM EDT
BDTX logo

BDTX Black Diamond Therapeutics Inc

$1.94
$0.03
(1.52%)
Pre-Market
Prev Close $1.97
EarningsNov 5
Mkt Cap$113.18M
Vol53.00

About BDTX

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases. It is currently focused on advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
66

Bullish Sentiment

How do you feel about BDTX?

superalby
$BDTX +28% last month. NSCLC best in class. Rumors about stunning preliminary data about GBM.strong cash runway. Wedbush target price $14 . TIME TO BUY OR REGRET 🚀
1
8
superalby
$BDTX 15th sept fireside chat at H.C. Wainwright 28th Annual Global Investment Conference.... investors will jump on the bandwagon...
1
5
superalby
$BDTX who is buying? BlackRock, Renaissance Technologies, Marshall Wace,and also superalby😅 Its time to jump on the bandwagon
1
3
BossTrade
$BDTX Unfortunately this is part of arbitrage in today’s market. You sometimes get sleeper deals but surely once news comes out they rip. Thing is, these low volume plays are also dominated by short algos which help consolidate lower levels for more explosive upsides. Crack open 12 month chart, More than evident
1
chole1
$BDTX just a flow / rigged market these days... Blossomhill up on nothing data at 5x mrkt cap of BDTX... mngt has too few larger holders / no bankers that manage the positions in difficult days
1
BossTrade
$BDTX Analyst target is $8-$14 Trading at cash now. The P2 data has partnership written all over it. Very promising therapy
4
BossTrade
$BDTX These investor conferences serve as institutional holder Q&A. They’re mostly focused on science and corporate viability. Which this thing has both. Only matter of time till it pivots. Major run up coming
3

Advertisement|Remove ads.